Faucher Quentin, Alarcan Hugo, Sauvage François-Ludovic, Forestier Lionel, Miquelestorena-Standley Elodie, Nadal-Desbarats Lydie, Arnion Hélène, Venhard Jean-Christophe, Brichart Nicolas, Bruyère Franck, Marquet Pierre, Barin-Le Guellec Chantal
P&T UMR1248, Université de Limoges, institut national de la santé et de la recherche médicale (INSERM), Limoges, France.
Service de biochimie et biologie moléculaire, CHRU de Tours, Tours, France.
Transplantation. 2022 Sep 1;106(9):1831-1843. doi: 10.1097/TP.0000000000004129. Epub 2022 Apr 20.
Ischemia-related injury during the preimplantation period impacts kidney graft outcome. Evaluating these lesions by a noninvasive approach before transplantation could help us to understand graft injury mechanisms and identify potential biomarkers predictive of graft outcomes. This study aims to determine the metabolomic content of graft perfusion fluids and its dependence on preservation time and to explore whether tubular transporters are possibly involved in metabolomics variations.
Kidneys were stored on hypothermic perfusion machines. We evaluated the metabolomic profiles of perfusion fluids (n = 35) using liquid chromatography coupled with tandem mass spectrometry and studied the transcriptional expression of tubular transporters on preimplantation biopsies (n = 26), both collected at the end of graft perfusion. We used univariate and multivariate analyses to assess the impact of perfusion time on these parameters and their relationship with graft outcome.
Seventy-two metabolites were found in preservation fluids at the end of perfusion, of which 40% were already present in the native conservation solution. We observed an increase of 23 metabolites with a longer perfusion time and a decrease of 8. The predictive model for time-dependent variation of metabolomics content showed good performance (R 2 = 76%, Q 2 = 54%, accuracy = 41%, and permutation test significant). Perfusion time did not affect the mRNA expression of transporters. We found no correlation between metabolomics and transporters expression. Neither the metabolomics content nor transporter expression was predictive of graft outcome.
Our results call for further studies, focusing on both intra- and extratissue metabolome, to investigate whether transporter alterations can explain the variations observed in the preimplantation period.
植入前阶段的缺血相关损伤会影响肾移植结果。在移植前通过非侵入性方法评估这些损伤有助于我们了解移植损伤机制,并识别预测移植结果的潜在生物标志物。本研究旨在确定移植灌注液的代谢组学内容及其对保存时间的依赖性,并探讨肾小管转运体是否可能参与代谢组学变化。
将肾脏保存在低温灌注机器上。我们使用液相色谱-串联质谱法评估灌注液(n = 35)的代谢组学谱,并研究植入前活检组织(n = 26)上肾小管转运体的转录表达,两者均在移植灌注结束时采集。我们使用单变量和多变量分析来评估灌注时间对这些参数的影响及其与移植结果的关系。
灌注结束时在保存液中发现了72种代谢物,其中40%已存在于天然保存溶液中。我们观察到随着灌注时间延长,23种代谢物增加,8种减少。代谢组学内容随时间变化的预测模型表现良好(R2 = 76%,Q2 = 54%,准确率 = 41%,置换检验显著)。灌注时间不影响转运体的mRNA表达。我们发现代谢组学与转运体表达之间没有相关性。代谢组学内容和转运体表达均不能预测移植结果。
我们的结果呼吁进一步开展研究,聚焦组织内和组织外代谢组,以调查转运体改变是否可以解释植入前阶段观察到的变化。